News by Kurt Niland

Merck developing possible Fosamax replacement

Back in January we explained how many pharmaceutical companies, following a Hollywood business model, have started to experience an erosion of their profits as patents expire on their “blockbuster” drugs. Aggressive, multi-billion-dollar marketing campaigns lead to multi-billion-dollar drug sales, but when patents expire, so do profits.

Read the rest of this entry »